Howard Franklin
Chief Tech/Sci/R&D Officer at ASSERTIO HOLDINGS, INC.
Profile
Howard J.
Franklin is currently a Senior Vice President-Medical at Assertio Holdings, Inc. Prior to this, he worked as the Chief Medical Officer at Salix Pharmaceuticals Ltd.
from 2018 to 2022.
He also held the position of Chief Medical Officer at Finch Therapeutics Group, Inc. Dr. Franklin has an MBA from LaSalle University, an undergraduate degree from Lehigh University, and a doctorate from Drexel University College of Medicine.
Howard Franklin active positions
| Companies | Position | Start |
|---|---|---|
| ASSERTIO HOLDINGS, INC. | Chief Tech/Sci/R&D Officer | 06/03/2023 |
Former positions of Howard Franklin
| Companies | Position | End |
|---|---|---|
| SALIX PHARMACEUTICALS, LTD. | Chief Tech/Sci/R&D Officer | 01/03/2022 |
| FINCH THERAPEUTICS GROUP, INC. | Chief Tech/Sci/R&D Officer | - |
Training of Howard Franklin
| Lehigh University | Undergraduate Degree |
| Drexel University College of Medicine | Doctorate Degree |
| LaSalle University | Masters Business Admin |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 2 |
|---|---|
| FINCH THERAPEUTICS GROUP, INC. | Health Services |
| ASSERTIO HOLDINGS, INC. | Health Technology |
| Private companies | 1 |
|---|---|
Salix Pharmaceuticals Ltd.
 Salix Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Salix Pharmaceuticals Ltd. develops and commercializes prescription drugs and medical devices used in the treatment of gastrointestinal diseases, endocrinology, hepatology, colorectal surgery, and internal medicine. It offers Anusol, Apriso, Colazal, Deflux, Diuril, Fenoglide, MoviPrep, Pepcid, Solesta, and Zegerid. The company was founded by randy W. Hamilton and Lorin K. Johnson in1989 and is headquartered in Bridgewater, NJ. | Health Technology |
- Stock Market
- Insiders
- Howard Franklin